• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problems Entrapment of Device (1212); Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/09/2023
Event Type  malfunction  
Manufacturer Narrative
A2: age at time of event: 18 years or older.Device eval / media analysis by manufacturer: the device was not returned for analysis as the stent was implanted.However, media was provided in the form of two videos.Both videos showed the stent being deployed.The bottom of the screen displayed what appeared to be the tip of the device, whereas the markerband on the sheath could be seen at the top of the screen.The stent did not appear to have opened evenly.
 
Event Description
It was reported that the stent partially deployed and stretched.A 6x120mm, 130 cm eluvia drug-eluting vascular stent system was selected for use to treat a vessel dissection.A contralateral approach was used to access the stenosed superficial femoral artery with a 6mm reference vessel diameter.Pre-dilation was performed with a 6x80mm, 135cm mustang balloon catheter.During deployment of the eluvia stent, the thumbwheel was turned until the end, but the stent could not be fully deployed.At the same time, the 0.018 v-18 guidewire was stuck with the delivery system.The pull grip was then used, but the stent could not be fully deployed.Instead, the whole system was pulled out to complete deployment.The stent structure elongated approximately 60mm.The procedure was completed with this device.No patient complications were reported, and the patient was stable following the procedure.
 
Manufacturer Narrative
A2: age at time of event: 18 years or older.Device eval by manufacturer: returned product consisted of an eluvia self-expanding stent system with a 0.014-inch guidewire stuck in the device.The stent was not returned as it was implanted.Media was provided in the form of two videos.Both videos showed the stent being deployed.The bottom of the screen displayed what appeared to be the tip of the device, whereas the markerband on the sheath could be seen at the top of the screen.The stent did not appear to have opened evenly.The outer sheath, tip, inner sheath, and the remainder of the device were checked for damage.Visual examination revealed a kink to the outer sheath at the nosecone.Microscopic examination revealed no additional damages.The handle was x-rayed, and the proximal inner was prolapsed.Product analysis found damage that would have contributed to the deployment issue, stent deformation, and guidewire entrapment.
 
Event Description
It was reported that the stent partially deployed and stretched.A 6x120mm, 130 cm eluvia drug-eluting vascular stent system was selected for use to treat a vessel dissection.A contralateral approach was used to access the stenosed superficial femoral artery with a 6mm reference vessel diameter.Pre-dilation was performed with a 6x80mm, 135cm mustang balloon catheter.During deployment of the eluvia stent, the thumbwheel was turned until the end, but the stent could not be fully deployed.At the same time, the 0.018 v-18 guidewire was stuck with the delivery system.The pull grip was then used, but the stent could not be fully deployed.Instead, the whole system was pulled out to complete deployment.The stent structure elongated approximately 60mm.The procedure was completed with this device.No patient complications were reported, and the patient was stable following the procedure.It was further reported that the eluvia delivery system was stuck with a non-boston scientific guidewire, not a v-18 guidewire.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17691350
MDR Text Key322745268
Report Number2124215-2023-47378
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeTW
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/06/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/05/2023
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0028462757
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/18/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/05/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0.018 V-18 GUIDEWIRE; ASAHI GLADIATOR GUIDEWIRE
-
-